Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Corteva Inc. Common Stock (CTVA) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

Corteva Inc. Common StockTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Corteva Inc. Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Corteva Inc. Common Stock trades at $13.74 (market cap $9.64B), while ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B). The key difference: Corteva Inc. Common Stock and ImmunityBio Inc. Common Stock are close in size by market cap, and Corteva Inc. Common Stock pays a 4.98% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Corteva Inc. Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.

CTVAIBRX
Market Cap
$9.64B$10.33B
Volume
41,241,25511,745,198
Sector
Basic MaterialsHealth
52-Week High
$90.51$11.55
52-Week Low
$11.92$1.98
Typical Hold Time
0 Days0 Days
Enterprise Value
$12.15B$10.79B
Dividend Yield
4.98%—

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTVA
100% Buy0% Sell
Avg holding period · 0 Days
IBRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Corteva Inc. Common Stock

Corteva provides seeds, crop protection products, and digital tools for agriculture. Its products are used by farmers to manage crop production and protect yields.

Read more on CTVA →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →